MNZO OTC
Manzo Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.0%
5Y: -66.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+30.0% ▲
Capital Expenditures
$2K
+27.1% ▲
Free Cash Flow
-$1M
+30.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2K
+99.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2004 |
|---|---|---|
| — Operating Activities — | ||
| Net Income | -$4M | -$4M |
| Depreciation & Amort. | $0 | $0 |
| Stock-Based Comp. | $0 | $0 |
| Change in Working Capital | $789K | $3M |
| Other Non-Cash Items | $2M | -$49K |
| Operating Cash Flow | -$2M | -$1M |
| — Investing Activities — | ||
| Capital Expenditures | -$3K | -$2K |
| Acquisitions (Net) | $0 | $0 |
| Investment Purchases | $0 | $0 |
| Investment Sales | $0 | $0 |
| Other Investing | $0 | $0 |
| Investing Cash Flow | -$3K | -$2K |
| — Financing Activities — | ||
| Net Debt Issuance | $840K | $1M |
| Stock Repurchased | $0 | $0 |
| Dividends Paid | $0 | $0 |
| Other Financing | $0 | $0 |
| Financing Cash Flow | $840K | $1M |
| Net Change in Cash | -$757K | -$2K |
| Cash End of Period | $12K | $10K |
| Free Cash Flow | -$2M | -$1M |